Literature DB >> 29426041

Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis.

C A Naranjo-Galvis1,2, A de-la-Torre3,4, L E Mantilla-Muriel1, L Beltrán-Angarita5, X Elcoroaristizabal-Martín6, R McLeod7, N Alliey-Rodriguez8, I J Begeman7, C López de Mesa9, J E Gómez-Marín3, J C Sepúlveda-Arias10.   

Abstract

Toxoplasmosis is caused by infection with the protozoan parasite Toxoplasma gondii, which has the capacity to infect all warm-blooded animals worldwide. Toxoplasmosis is a major cause of visual defects in the Colombian population; however, the association between genetic polymorphisms in cytokine genes and susceptibility to ocular toxoplasmosis has not been studied in this population. This work evaluates the associations between polymorphisms in genes coding for the cytokines tumor necrosis factor alpha (TNF-α) (rs1799964, rs1800629, rs1799724, rs1800630, and rs361525), interleukin 1β (IL-1β) (rs16944, rs1143634, and rs1143627), IL-1α (rs1800587), gamma interferon (IFN-γ) (rs2430561), and IL-10 (rs1800896 and rs1800871) and the presence of ocular toxoplasmosis (OT) in a sample of a Colombian population (61 patients with OT and 116 healthy controls). Genotyping was performed with the "dideoxynucleotide (ddNTP) primer extension" technique. Functional-effect predictions of single nucleotide polymorphisms (SNPs) were done by using FuncPred. A polymorphism in the IL-10 gene promoter (-1082G/A) was significantly more prevalent in OT patients than in controls (P = 1.93e-08; odds ratio [OR] = 5.27e+03; 95% confidence interval [CI] = 3.18 to 8.739; Bonferroni correction [BONF] = 3.48e-07). In contrast, haplotype "AG" of the IL-10 gene promoter polymorphisms (rs1800896 and rs1800871) was present at a lower frequency in OT patients (P = 7e-04; OR = 0.10; 95% CI = 0.03 to 0.35). The +874A/T polymorphism of IFN-γ was associated with OT (P = 3.37e-05; OR = 4.2; 95% CI = 2.478 to 7.12; BONF = 6.07e-04). Haplotype "GAG" of the IL-1β gene promoter polymorphisms (rs1143634, rs1143627, and rs16944) appeared to be significantly associated with OT (P = 0.0494). The IL-10, IFN-γ, and IL-1β polymorphisms influence the development of OT in the Colombian population.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  cytokines; ocular toxoplasmosis; single nucleotide polymorphisms; susceptibility

Mesh:

Substances:

Year:  2018        PMID: 29426041      PMCID: PMC5865049          DOI: 10.1128/IAI.00597-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  85 in total

1.  Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.

Authors:  Tze Guan Tan; Ernest Mui; Hua Cong; William H Witola; Alexandre Montpetit; Stephen P Muench; John Sidney; Jeff Alexander; Alessandro Sette; Michael E Grigg; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-03-26       Impact factor: 3.641

Review 2.  How frequent is altered gene expression among susceptibility genes to human complex disorders?

Authors:  Philippe H Jais
Journal:  Genet Med       Date:  2005-02       Impact factor: 8.822

3.  NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells.

Authors:  William H Witola; Ernest Mui; Aubrey Hargrave; Susan Liu; Magali Hypolite; Alexandre Montpetit; Pierre Cavailles; Cordelia Bisanz; Marie-France Cesbron-Delauw; Gilbert J Fournié; Rima McLeod
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

4.  Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese.

Authors:  H W Tso; W K Ip; W P Chong; C M Tam; A K S Chiang; Y L Lau
Journal:  Genes Immun       Date:  2005-06       Impact factor: 2.676

5.  Association of IL-1β +3954 C/T and IL-10-1082 G/A cytokine gene polymorphisms with susceptibility to tuberculosis.

Authors:  P Meenakshi; S Ramya; T Shruthi; J Lavanya; H H Mohammed; S A Mohammed; V Vijayalakshmi; G Sumanlatha
Journal:  Scand J Immunol       Date:  2013-07       Impact factor: 3.487

6.  Early serum biomarker networks in infants with distinct retinochoroidal lesion status of congenital toxoplasmosis.

Authors:  Thádia Evelyn de Araújo; Jordana Grazziela Coelho-Dos-Reis; Samantha Ribeiro Béla; Ana Carolina Aguiar Vasconcelos Carneiro; Anderson Silva Machado; Ludmila Melo Cardoso; Ágata Lopes Ribeiro; Michelle Hallais França Dias; Gláucia Manzan Queiroz Andrade; Daniel Vitor Vasconcelos-Santos; José Nélio Januário; Andréa Teixeira-Carvalho; Ricardo Wagner Almeida Vitor; Eloisa Amália Vieira Ferro; Olindo Assis Martins-Filho
Journal:  Cytokine       Date:  2017-02-28       Impact factor: 3.861

Review 7.  Epistasis and its implications for personal genetics.

Authors:  Jason H Moore; Scott M Williams
Journal:  Am J Hum Genet       Date:  2009-09       Impact factor: 11.025

8.  Systemic T cell response to Toxoplasma gondii antigen in patients with ocular toxoplasmosis.

Authors:  Fatih Fatoohi; Grégoire Jacques Noël Cozon; Martine Wallon; Laurent Kodjikian; François Peyron
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

9.  Contribution of IL6 -174 G>C and IL1B +3954 C>T polymorphisms to congenital infection with Toxoplasma gondii.

Authors:  W Wujcicka; Z Gaj; J Wilczyński; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-18       Impact factor: 3.267

10.  Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels.

Authors:  Alejandra de-la-Torre; Arnaud Sauer; Alexander W Pfaff; Tristan Bourcier; Julie Brunet; Claude Speeg-Schatz; Laurent Ballonzoli; Odile Villard; Daniel Ajzenberg; Natarajan Sundar; Michael E Grigg; Jorge E Gomez-Marin; Ermanno Candolfi
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21
View more
  6 in total

Review 1.  Toxoplasmosis in Germany.

Authors:  Uwe Pleyer; Uwe Gross; Dirk Schlüter; Henrik Wilking; Frank Seeber
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

2.  Interferon-γ and IL-10 Release Assay for Patients with Ocular Toxoplasmosis.

Authors:  Marcelo Rudzinski; Lais Pardini; Mariana Bernstein; Gastón Moré; Marina Khoury; Silvana Carolina Duarte; Carina Argüelles; Silvia Reina; José Raúl Oubiña
Journal:  Am J Trop Med Hyg       Date:  2020-09-03       Impact factor: 3.707

Review 3.  Pathophysiology of ocular toxoplasmosis: Facts and open questions.

Authors:  Valentin Greigert; Faiza Bittich-Fahmi; Alexander W Pfaff
Journal:  PLoS Negl Trop Dis       Date:  2020-12-31

Review 4.  Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview.

Authors:  Mariangela Soberón Felín; Kanix Wang; Aliya Moreira; Andrew Grose; Karen Leahy; Ying Zhou; Fatima Alibana Clouser; Maryam Siddiqui; Nicole Leong; Perpetua Goodall; Morgan Michalowski; Mahmoud Ismail; Monica Christmas; Stephen Schrantz; Zuleima Caballero; Ximena Norero; Dora Estripeaut; David Ellis; Catalina Raggi; Catherine Castro; Davina Moossazadeh; Margarita Ramirez; Abhinav Pandey; Kevin Ashi; Samantha Dovgin; Ashtyn Dixon; Xuan Li; Ian Begeman; Sharon Heichman; Joseph Lykins; Delba Villalobos-Cerrud; Lorena Fabrega; José Luis Sanchez Montalvo; Connie Mendivil; Mario R Quijada; Silvia Fernández-Pirla; Valli de La Guardia; Digna Wong; Mayrene Ladrón de Guevara; Carlos Flores; Jovanna Borace; Anabel García; Natividad Caballero; Claudia Rengifo-Herrera; Maria Theresa Moreno de Saez; Michael Politis; Kristen Wroblewski; Theodore Karrison; Stephanie Ross; Mimansa Dogra; Vishan Dhamsania; Nicholas Graves; Marci Kirchberg; Kopal Mathur; Ashley Aue; Carlos M Restrepo; Alejandro Llanes; German Guzman; Arturo Rebellon; Kenneth Boyer; Peter Heydemann; A Gwendolyn Noble; Charles Swisher; Peter Rabiah; Shawn Withers; Teri Hull; Chunlei Su; Michael Blair; Paul Latkany; Ernest Mui; Daniel Vitor Vasconcelos-Santos; Alcibiades Villareal; Ambar Perez; Carlos Andrés Naranjo Galvis; Mónica Vargas Montes; Nestor Ivan Cardona Perez; Morgan Ramirez; Cy Chittenden; Edward Wang; Laura Lorena Garcia-López; Juliana Muñoz-Ortiz; Nicolás Rivera-Valdivia; María Cristina Bohorquez-Granados; Gabriela Castaño de-la-Torre; Guillermo Padrieu; Juan David Valencia Hernandez; Daniel Celis-Giraldo; Juan Alejandro Acosta Dávila; Elizabeth Torres; Manuela Mejia Oquendo; José Y Arteaga-Rivera; Dan L Nicolae; Andrey Rzhetsky; Nancy Roizen; Eileen Stillwaggon; Larry Sawers; Francois Peyron; Martine Wallon; Emanuelle Chapey; Pauline Levigne; Carmen Charter; Migdalia De Frias; Jose Montoya; Cindy Press; Raymund Ramirez; Despina Contopoulos-Ioannidis; Yvonne Maldonado; Oliver Liesenfeld; Carlos Gomez; Kelsey Wheeler; Ellen Holfels; David Frim; David McLone; Richard Penn; William Cohen; Samantha Zehar; James McAuley; Denis Limonne; Sandrine Houze; Sylvie Abraham; Raphael Piarroux; Vera Tesic; Kathleen Beavis; Ana Abeleda; Mari Sautter; Bouchra El Mansouri; Adlaoui El Bachir; Fatima Amarir; Kamal El Bissati; Alejandra de-la-Torre; Gabrielle Britton; Jorge Motta; Eduardo Ortega-Barria; Isabel Luz Romero; Paul Meier; Michael Grigg; Jorge Gómez-Marín; Jagannatha Rao Kosagisharaf; Xavier Sáez Llorens; Osvaldo Reyes; Rima McLeod
Journal:  Curr Pediatr Rep       Date:  2022-08-22

5.  Influence of Two Major Toxoplasma Gondii Virulence Factors (ROP16 and ROP18) on the Immune Response of Peripheral Blood Mononuclear Cells to Human Toxoplasmosis Infection.

Authors:  Alejandro Hernández-de-Los-Ríos; Mateo Murillo-Leon; Luz Eliana Mantilla-Muriel; Ailan Farid Arenas; Mónica Vargas-Montes; Néstor Cardona; Alejandra de-la-Torre; Juan Carlos Sepúlveda-Arias; Jorge Enrique Gómez-Marín
Journal:  Front Cell Infect Microbiol       Date:  2019-12-04       Impact factor: 5.293

6.  Association between Interleukin-10 Gene Polymorphisms and Behcet's Disease Susceptibility: Evidence from a Meta-Analysis.

Authors:  Xue-Feng Li; Zhi-Zhen Huang; Yuan-Yuan Hu; Yu-Ming Niu; Jun-Wei Cai
Journal:  J Immunol Res       Date:  2020-06-19       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.